William J Fulp
Overview
Explore the profile of William J Fulp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
deCamp A, Corcoran M, Fulp W, Willis J, Cottrell C, Bader D, et al.
NPJ Vaccines
. 2024 Mar;
9(1):58.
PMID: 38467663
Vaccine priming immunogens that activate germline precursors for broadly neutralizing antibodies (bnAbs) have promise for development of precision vaccines against major human pathogens. In a clinical trial of the eOD-GT8...
2.
Cohen K, De Rosa S, Fulp W, deCamp A, Fiore-Gartland A, Mahoney C, et al.
Sci Transl Med
. 2023 May;
15(697):eadf3309.
PMID: 37224227
The engineered outer domain germline targeting version 8 (eOD-GT8) 60-mer nanoparticle was designed to prime VRC01-class HIV-specific B cells that would need to be matured, through additional heterologous immunizations, into...
3.
deCamp A, Corcoran M, Fulp W, Willis J, Cottrell C, Bader D, et al.
medRxiv
. 2023 Mar;
PMID: 36993183
One-sentence Summary: Human genetic variation can modulate the strength of vaccine-induced broadly neutralizing antibody precursor B cell responses.
4.
Leggat D, Cohen K, Willis J, Fulp W, deCamp A, Kalyuzhniy O, et al.
Science
. 2022 Dec;
378(6623):eadd6502.
PMID: 36454825
Broadly neutralizing antibodies (bnAbs) can protect against HIV infection but have not been induced by human vaccination. A key barrier to bnAb induction is vaccine priming of rare bnAb-precursor B...
5.
Perdiguero B, Asbach B, Gomez C, Kostler J, Barnett S, Koutsoukos M, et al.
Front Immunol
. 2022 Aug;
13:939627.
PMID: 35935978
To control HIV infection there is a need for vaccines to induce broad, potent and long-term B and T cell immune responses. With the objective to accelerate and maintain the...
6.
Yang G, Yuan Z, Ahmed K, Welsh E, Fulp W, Gonzalez R, et al.
Transl Oncol
. 2021 Jul;
14(10):101165.
PMID: 34246048
Background: Soft-tissue sarcomas (STS) are heterogeneous with variable response to radiation therapy (RT). Utilizing the radiosensitivity index (RSI) we estimated the radiobiologic ratio of lethal to sublethal damage (α/β), genomic-adjusted...
7.
Sun J, Mathias B, Laronga C, Sun W, Zhou J, Fulp W, et al.
J Natl Compr Canc Netw
. 2021 Jan;
19(1):40-47.
PMID: 33406495
Background: Results of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial supports omission of completion axillary lymph node dissection (CLND) after breast-conservation surgery with a positive sentinel lymph...
8.
Mathias B, Sun J, Sun W, Zhou J, Fulp W, Laronga C, et al.
Clin Breast Cancer
. 2020 Sep;
21(1):74-79.
PMID: 32917535
Background: The standard of care for clinically node-negative (cN0) patients following positive sentinel lymph node biopsy (SLNB) was completion axillary lymph node dissection (CALND). Publication of ACOSOG Z0011 in 2010...
9.
Sun J, Mathias B, Sun W, Fulp W, Zhou J, Laronga C, et al.
Ann Surg Oncol
. 2020 Jul;
28(1):320-329.
PMID: 32613363
Background: The Society of Surgical Oncology's Choosing Wisely guidelines recommend against routine sentinel lymph node biopsy (SLNB) in clinically node-negative (cN0), hormone receptor (HR)-positive breast cancer patients aged ≥ 70 ...
10.
Bettampadi D, Sirak B, Fulp W, Abrahamsen M, Villa L, Lazcano-Ponce E, et al.
Papillomavirus Res
. 2020 May;
9:100199.
PMID: 32464335
Introduction: Oral human papillomavirus (HPV) attributable oropharyngeal cancers are on the rise in many countries. Oral HPV infections among healthy individuals are commonly detected using oral gargle samples. However, the...